ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -3.1% | 5,932 | -7.9% | 0.00% | – |
| Q2 2023 | $97 | -34.9% | 6,440 | -37.0% | 0.00% | – |
| Q1 2023 | $149 | +2.1% | 10,228 | -5.1% | 0.00% | – |
| Q4 2022 | $146 | -99.2% | 10,772 | +786.6% | 0.00% | – |
| Q3 2022 | $19,000 | – | 1,215 | +3275.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 36 | -97.9% | 0.00% | – |
| Q1 2022 | $16,000 | – | 1,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,750,000 | 26.57% |
| 5AM Venture Management, LLC | 4,408,379 | $69,476,000 | 13.31% |
| 72 Investment Holdings, LLC | 509,023 | $8,022,000 | 6.36% |
| TCG Crossover Management, LLC | 642,189 | $10,121,000 | 3.04% |
| StepStone Group LP | 761,277 | $11,998,000 | 1.71% |
| Nan Fung Group Holdings Ltd | 141,593 | $2,232,000 | 1.42% |
| Redmile Group, LLC | 1,954,419 | $30,802,000 | 1.20% |
| Baker Brothers Advisors | 4,865,819 | $76,685,000 | 0.50% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,655,000 | 0.04% |
| Laurion Capital Management LP | 199,066 | $3,137,000 | 0.02% |